Robert S. Mills, Director at TFF Pharmaceuticals, Inc. (TFFP), bought 40,000 shares at $0.25 ($10K) on 2023-08-15, disclosed to the SEC on 2023-08-15.
Open-market purchase of $10k TFFP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| TFFP | SELL | 2020-12-15 | $665K | — | Filing → |
| TFFP | BUY | 2019-10-29 | $25K | — | Filing → |